Difficulty: Medium
Average Score: 82%
Practice
Peripheral adverse effects of levodopa, including nausea, hypotension, and cardiac arrhythmias, can be diminished by including which of the following drugs in the therapy?
Correct answer
C
Rationale
Levodopa's peripheral conversion to dopamine by dopa decarboxylase causes nausea (via chemoreceptor trigger zone stimulation), hypotension, and arrhythmias. Carbidopa, a peripheral dopa decarboxylase inhibitor, prevents this conversion outside the CNS, reducing these side effects while increasing levodopa's brain availability. Amantadine, an NMDA antagonist, boosts dopamine release but doesn't address peripheral metabolism. Ropinirole, a dopamine agonist, bypasses levodopa but doesn't mitigate its effects. Tolcapone, a COMT inhibitor, prolongs levodopa's action but can increase peripheral dopamine if used alone, worsening side effects. Carbidopa's specific blockade of peripheral decarboxylation directly counters these adverse effects, making it the essential adjunct in levodopa therapy.